Baragano-Raneros, Aroa; Minguela-Puras, Alfredo; Rodríguez, Ramon-M; Colado, Enrique; Bernal, Teresa; Anguita, Eduardo; Vasco-Mogorron, Adela; Chaparro-Gil, Alberto; Vidal-Castineira, J-R; Márquez-Kisinousky, Leonardo; Díaz-Bulnes, Paula; Martínez-Marin, Amelia; García-Garay, María-Carmen; Suárez-Álvarez, Beatriz; López-Larrea, Carlos
(IMPACT JOURNALS LLC, 2017-05-09)
Acute myeloid leukemia (AML) is a disease with great morphological and genetic heterogeneity, which complicates its prognosis and treatment. The hypomethylating agents azacitidine (Vidaza®, AZA) and decitabine (Dacogen®, ...